Presentation Information
[O15-04]Safety and immunogenecity of mRNA-1345 vaccine in Japanese older adults aged ≧ 60 years
*Osamu Kogawara1, Lauren Wilson2, Caroline Reuter2, Shraddha Mehta2, Archana Kapoor2, Lan Lan2, Honghong Zhou2, Jaya Goswami2, Frances Priddy2, Rituparna Das2 (1. Moderna Japan Co., Ltd., 2. Moderna, Inc.)